Kezar Life Sciences, Inc. (KZR) DCF Valuation

Kezar Life Sciences, Inc. (KZR) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Kezar Life Sciences, Inc. (KZR) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you're an investor or analyst, this (KZR) DCF Calculator is your go-to tool for accurate valuation. Preloaded with real data from Kezar Life Sciences, Inc., you can adjust forecasts and observe the effects in real time.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 7.0 7.0 7.0 7.0 7.0 7.0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -34.4 -40.3 -53.0 -66.1 -99.3 4.2 4.2 4.2 4.2 4.2
EBITDA, % 100 100 100 100 -1417.91 60 60 60 60 60
Depreciation 1.3 1.5 1.5 1.0 1.1 5.8 5.8 5.8 5.8 5.8
Depreciation, % 100 100 100 100 15.23 83.05 83.05 83.05 83.05 83.05
EBIT -35.7 -41.8 -54.5 -67.1 -100.3 4.2 4.2 4.2 4.2 4.2
EBIT, % 100 100 100 100 -1433.14 60 60 60 60 60
Total Cash 78.2 140.4 208.4 276.6 201.4 7.0 7.0 7.0 7.0 7.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 0
Inventories 1.2 2.0 2.5 .0 .0 5.6 5.6 5.6 5.6 5.6
Inventories, % 100 100 100 100 0 80 80 80 80 80
Accounts Payable .8 2.4 2.0 2.5 8.3 7.0 7.0 7.0 7.0 7.0
Accounts Payable, % 100 100 100 100 117.87 100 100 100 100 100
Capital Expenditure -.6 -.2 -.3 -1.6 -1.8 -.4 -.4 -.4 -.4 -.4
Capital Expenditure, % 100 100 100 100 -25.86 -5.17 -5.17 -5.17 -5.17 -5.17
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -32.1 -39.0 -53.1 -64.3 -100.3 4.0 4.0 4.0 4.0 4.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -31.8 -36.9 -52.8 -61.9 -95.3 -3.0 9.5 9.5 9.5 9.5
WACC, % 5.55 5.56 5.57 5.56 5.58 5.56 5.56 5.56 5.56 5.56
PV UFCF
SUM PV UFCF 28.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 10
Terminal Value 271
Present Terminal Value 207
Enterprise Value 235
Net Debt -17
Equity Value 252
Diluted Shares Outstanding, MM 73
Equity Value Per Share 3.47

What You Will Get

  • Real Kezar Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Kezar Life Sciences, Inc. (KZR).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates to fit your analysis.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Kezar's fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections specific to Kezar Life Sciences, Inc. (KZR).
  • Time-Saving and Accurate: Skip building models from scratch while ensuring precision and flexibility in your financial assessments.

Key Features

  • Comprehensive Financial Data: Gain access to precise historical data and future forecasts for Kezar Life Sciences, Inc. (KZR).
  • Adjustable Forecast Parameters: Modify highlighted cells for key metrics like WACC, growth rates, and profit margins.
  • Real-Time Calculations: Instant updates for DCF, Net Present Value (NPV), and cash flow analysis.
  • User-Friendly Dashboard: Intuitive charts and summaries to help visualize your valuation outcomes.
  • Designed for All Skill Levels: An easy-to-navigate framework suitable for investors, CFOs, and consultants alike.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Kezar Life Sciences' pre-filled financial data and projections.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you modify assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for your investment strategies.

Why Choose This Calculator for Kezar Life Sciences, Inc. (KZR)?

  • Accuracy: Utilizes real Kezar financial data for precise calculations.
  • Flexibility: Allows users to easily adjust and test various input parameters.
  • Time-Saving: Eliminate the need to create a DCF model from the ground up.
  • Professional-Grade: Crafted with the precision and usability expected by industry leaders.
  • User-Friendly: Intuitive interface suitable for users with varying levels of financial expertise.

Who Should Use This Product?

  • Professional Investors: Create comprehensive and accurate valuation models for portfolio assessment of Kezar Life Sciences, Inc. (KZR).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights to clients regarding Kezar Life Sciences, Inc. (KZR) stock.
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech companies like Kezar Life Sciences, Inc. (KZR) are valued in the marketplace.

What the Template Contains

  • Historical Data: Includes Kezar Life Sciences’ past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Kezar Life Sciences’ intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Kezar Life Sciences’ financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.